Progress & Achievements

English / Français

Prioritisation Licences Access to Medicines Tracker Contribution to Universal Health Coverage Endorsements Impact

Prioritisation

Discover

Licences

To date, MPP has signed agreements with 18 patent holders for 14 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, three oral antiviral treatments for COVID-19 and 12 COVID-19 technologies.

Discover

Access to Medicines Tracker

Each quarter, we monitor the progress of our generic partners in developing, filing and selling MPP’s licensed medicines, in countries where access could not have been possible without our work.

Discover

Contribution to Universal Health Coverage

Enabling access to affordable medicines for those who need them most, wherever they live, is MPP’s contribution to achieve Universal Health Coverage.

Discover

Endorsements

Hear from some of our partners on what they have to say about our work.

Discover

Impact

From sales of medicines to impact on peoples’ lives, the Medicines Patent Pool’s work is a game-changer in the access to treatments space.

Discover